Renal disease associated with injectable amoxicillin with or without clavulanic acid

被引：0

作者：

Bordet, C. ^{[1
]}

Letinier, L. ^{[1
]}

Perino, J. ^{[2
]}

Miremont, G. ^{[1
]}

Pariente, A. ^{[2
]}

机构：

[1] CRPV, Ctr Reg PharmacoVigilance, Bordeaux, France

[2] Univ Bordeaux, INSERM, Bordeaux, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷

关键词：

pharmacoepidemiology; amoxicillin; crystalluria; pharmacovigilance; drug safety;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PS-021

引用

页码：103 / 103

页数：1

共 2 条

[1] Amoxicillin-induced crystal nephropathy: A nationwide French pharmacovigilance databases study [J].

Thomas, Laure ;

Le Beller, Christine ;

Trenque, Thierry ;

Michot, Joelle ;

Zenut, Marie ;

Letavernier, Emmanuel ;

Mongardon, Nicolas ;

Vodovar, Dominique .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (11) :2256-2265

[2] Dramatic Increase of Amoxicillin-Induced Crystal Nephropathy Found in a Cohort Study of French Pharmacovigilance Centers [J].

Vodovar, Dominique ;

Thomas, Laure ;

Mongardon, Nicolas ;

Lepeule, Raphael ;

Lebrun-Vignes, Benedicte ;

Biour, Michel ;

Netzer, Florence ;

Haouache, Hakim ;

Le Beller, Christine ;

Dhonneur, Gilles .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)

← 1 →